|
Predictive value of ultra-high ESR1 mRNA expression in early breast cancer. |
|
|
Employment - STRATIFYER Molecular Pathology |
Leadership - STRATIFYER Molecular Pathology |
Stock and Other Ownership Interests - STRATIFYER Molecular Pathology |
Research Funding - BioNTech (Inst) |
Patents, Royalties, Other Intellectual Property - STRATIFYER Molecular Pathology |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
|
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - STRATIFYER Molecular Pathology |
|
|
No Relationships to Disclose |